Xu Bin, Gu Shu-Yan, Zhou Ning-Ming, Jiang Jun-Jie
Department of Ultrasound, Shanghai Fifth People's Hospital, Fudan University, 128 Ruili Road, Minhang District, Shanghai, 200240, China.
Open Life Sci. 2023 Aug 11;18(1):20220671. doi: 10.1515/biol-2022-0671. eCollection 2023.
High thyroid stimulating hormone (TSH) levels may stimulate papillary thyroid cancer (PTC) cell proliferation; however, the relationship between TSH levels and PTC risk remains controversial. We aim to ascertain the association through a meta-analysis. Literature searches were conducted in PubMed, Embase, and Web of Science databases. After literature screening, the methodological quality was assessed using the Newcastle-Ottawa Scale and Agency for Healthcare Research and Quality methods. Cochran's and tests were used to evaluate heterogeneity in the meta-analysis. Egger's test was applied to assess publication bias. A total of 12 eligible studies were included in this meta-analysis; all were of moderate and high methodological quality. The pooled results suggested that increased TSH levels were significantly associated with PTC risk; however, the included studies were significantly heterogeneous. Stratification analysis indicated that the heterogeneity might be from the area or type of control. Although significant publication bias existed among the studies, the trim-and-fill method and sensitivity analysis revealed that the combined results were stable and robust. TSH levels are significantly associated with the PTC risk; however, more high-quality studies in large sample sizes are recommended to verify the extrapolation of these findings.
高促甲状腺激素(TSH)水平可能刺激甲状腺乳头状癌(PTC)细胞增殖;然而,TSH水平与PTC风险之间的关系仍存在争议。我们旨在通过荟萃分析确定这种关联。在PubMed、Embase和Web of Science数据库中进行文献检索。经过文献筛选,使用纽卡斯尔-渥太华量表和医疗保健研究与质量机构的方法评估方法学质量。在荟萃分析中使用 Cochr an检验和 检验来评估异质性。应用Egger检验评估发表偏倚。本荟萃分析共纳入12项符合条件的研究;所有研究的方法学质量均为中等及以上。汇总结果表明,TSH水平升高与PTC风险显著相关;然而,纳入的研究存在显著异质性。分层分析表明,异质性可能源于对照的地区或类型。尽管研究之间存在显著的发表偏倚,但通过剪补法和敏感性分析表明,合并结果稳定且可靠。TSH水平与PTC风险显著相关;然而,建议开展更多大样本量的高质量研究来验证这些结果的外推性。